Bio-Rad Laboratories (BIO.B) Scheduled to Post Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO.B) will be posting its quarterly earnings results after the market closes on Thursday, August 1st.

Bio-Rad Laboratories (NYSE:BIO.B) last released its quarterly earnings data on Tuesday, May 7th. The company reported $2.29 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The firm had revenue of $610.82 million during the quarter.

Bio-Rad Laboratories Price Performance

Shares of Bio-Rad Laboratories stock opened at $294.23 on Tuesday. The company has a current ratio of 6.57, a quick ratio of 4.89 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average is $284.71 and its two-hundred day moving average is $305.85. Bio-Rad Laboratories has a 1 year low of $271.00 and a 1 year high of $373.78.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.